Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 May 25;7(2):4.
doi: 10.3390/jpm7020004.

Development and Initial Assessment of a Patient Education Video about Pharmacogenetics

Rachel Mills  1 , Megan Ensinger  2 , Nancy Callanan  3 , Susanne B Haga  4
Affiliations

Development and Initial Assessment of a Patient Education Video about Pharmacogenetics

Rachel Mills et al. J Pers Med. .

Abstract

As few patient-friendly resources about pharmacogenetics are currently available, we aimed to create and assess a patient educational video on pharmacogenetic testing. A primary literature and resources review was conducted to inform the content and the format of the video. The educational video was then created using a commercially available animation program and pilot tested in focus groups of the general public and by an online survey of pharmacists. Emerging themes from the focus groups and survey indicate a desire for appropriate risk contextualization and specific examples when pharmacogenetic testing may be beneficial. Focus group participants also expressed a preference for a video with live action, and more text to reinforce concepts. Pharmacists generally felt that the video was understandable for patients and relevant for decision-making regarding testing. Using this initial feedback and the identification of important concepts to include in pharmacogenetics educational tools, we plan to revise the video, perform additional evaluations, and publish the video for public use in the future.

Keywords: educational video; patient education; pharmacogenetics.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Relling M.V., Evans W.E. Pharmacogenomics in the clinic. Nature. 2015;526:343–350. doi: 10.1038/nature15817. - DOI - PMC - PubMed
    1. Selkirk C.G., Weissman S.M., Anderson A., Hulick P.J. Physicians’ preparedness for integration of genomic and pharmacogenetic testing into practice within a major healthcare system. Genet. Test. Mol. Biomark. 2013;17:219–225. doi: 10.1089/gtmb.2012.0165. - DOI - PubMed
    1. Formea C.M., Nicholson W.T., McCullough K.B., Berg K.D., Berg M.L., Cunningham J.L., Merten J.A., Ou N.N., Stollings J.L. Development and evaluation of a pharmacogenomics educational program for pharmacists. Am. J. Pharm. Educ. 2013;77:10. doi: 10.5688/ajpe77110. - DOI - PMC - PubMed
    1. Haga S.B., Burke W., Ginsburg G.S., Mills R., Agans R. Primary care physicians’ knowledge of and experience with pharmacogenetic testing. Clin. Genet. 2012;82:388–394. doi: 10.1111/j.1399-0004.2012.01908.x. - DOI - PMC - PubMed
    1. Roederer M., Van Riper M., Valgus J., Knafl G., McLeod H. Knowledge, attitudes and education of pharmacists regarding pharmacogenetic testing. Pers. Med. 2012;9:19–27. doi: 10.2217/pme.11.87. - DOI - PubMed

LinkOut - more resources